The company has set a high standard for itself: a maximum-limit TOTOX value of 5 for its entire AlaskOmega line.
Photo © iStockphoto.com/numbeos
Omega-3 supplier Organic Technologies (Coshocton, OH) is raising its own standards for fish oil freshness even further. The company recently announced that it is tightening its Total Oxidation (TOTOX) specification limit significantly for its entire AlaskOmega fish oil line. TOTOX is an industry-wide value measuring oil freshness and accounts for both primary and secondary oil oxidation.
Knowing that AlaskOmega TOTOX values are usually somewhere between 0 and 3, the company has set a high standard for itself-a maximum-limit TOTOX value of 5 for its entire line, officially ensuring a very high freshness level henceforth.
For comparison, the industry-standard TOTOX limit set by the Global Organization for EPA and DHA Omega-3 (GOED) is 26-much higher than the TOTOX of 5 that Organic Technologies plans to adhere to.
“Lowering the TOTOX limit on all AlaskOmega products will help us better represent the superior freshness of our omega-3 ingredients,” said Steve Dillingham, global director for AlaskOmega Ingredients, in a press release. “Fresher oil translates into better product stability, longer shelf life, and optimal sensory characteristics for finished goods incorporating AlaskOmega,” resulting in fresher and better-tasting retail products, he added.
The company says it is able to meet such a strict TOTOX target because of its “careful and unique” supply chain: “Raw oil is extracted from the trimmings of MSC-certified Wild Alaska Pollock sourced from the Bering Sea immediately after catch, so raw material is of the highest quality. The oil is then processed through a careful purification and concentration process in the company’s NSF-certified manufacturing facility to extract and purify EPA and DHA concentrates to high purity levels (80% EPA + DHA). Products are kept away from oxygen throughout the entire process…”
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine
jennifer.grebow@ubm.com
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.